Severe alopecia areata in adolescents
Deuruxolitinib
Dr Aayush Gupta is the principal investigator at Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune for a placebo-controlled study of deuruxolitinib in severe alopecia areata in adolescents, sponsored by Sun Pharma. Status: submitted to DCGI.
- Phase
- Placebo-controlled
- Sponsor
- Sun Pharma
- Status
- Awaiting approval: Submitted to DCGI
- Principal investigator
- Dr Aayush Gupta
- Site
- Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune
- Condition
- Severe alopecia areata in adolescents
Official title
A Double-Blind, Randomized, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescent Patients with Severe Alopecia Areata with an Open-Label Extension Period
Other trials
- Phase 0 · Johnson & JohnsonMultibacillary leprosy, treatment monitoringOpens October 2026
- Phase 2 · Ahammune BiosciencesNon-segmental vitiligoOpens October 2026
- Observational · Systopic LaboratoriesHair health in adultsOpens October 2026
- Phase 4 · Johnson & JohnsonPsoriasisOpens November 2026
- Phase 3 · Johnson & JohnsonMultibacillary leprosyUnder way since January 2025
- Registry · PfizerAtopic dermatitis, alopecia areata and vitiligoStarted March 2025, completed